Searched for
RANITIDINE NDMA
Monitor presence of potentially carcinogenic chemical in Ranitidine: DCGI to drug controllersThe DCGI has directed state and UT drug controllers to monitor levels of the potentially carcinogenic NDMA in Ranitidine, an antacid. This ...- Ranitidine ban deferred despite cancer concernsDespite concerns about cancer-causing agents in Ranitidine and an expert panel's recommendation to suspend it, India's drug advisory body h...
- Buy J B Chemicals & Pharmaceuticals, target price Rs 2,225: JM FinancialJM Financial maintains a buy call on J B Chemicals & Pharmaceuticals, setting a target price of Rs 2,225. The brokerage believes a ban on r...
- Drugmaker GSK settles another California lawsuit on heartburn drug ZantacGlaxoSmithKline (GSK) has announced that it will confidentially settle another lawsuit in California regarding its discontinued heartburn d...
- No plans to reintroduce Zinetac in India: GSKBritish drugmaker GSK said it has no plans to reintroduce its once top-selling heartburn medication Zinetac (ranitidine) brand in India, de...
- GSK sends notices to Akums, Associate over 'Zinetac' brandThe Indian unit of British drugmaker GSK further alleged that Nicholas Healthcare and Akums are also using identical packaging to take adva...
- Granules India says 'voluntarily' recalling ranitidine tabsGranules India has said that it has received multiple queries on the news item for recall of ranitidine by the drug firm. The company is in...
- Glenmark Pharmaceutical Inc recalls ranitidine tablets in USThe tablets are being recalled because of the presence or potential presence of N-nitrosodimethylamine (NDMA) levels above the acceptable d...
- Glenmark recalls over 2 lakh cartons of product in USThe ongoing voluntary class II recall is on account of defective delivery system with "complaints for difficulty in pushing the plunger of ...
- Strides Pharma relaunches Ranitidine tablets in USThe company had suspended sales of its generic Ranitidine tablets after the USFDA found contamination in some Ranitidine tablets sold by va...
- Our drug Ranitidine is safe: Strides PharmaRanitidine is a commonly prescribed medicine for countering acidity and is on the WHO’s Model List of Essential Medicines. In India, a host...
- Ranitidine recall impacts Dr Reddy's P&L by Rs 40-croreDr Reddy's Laboratories which initiated a voluntary recall of its Ranitidine at the retail level for over-the-counter products and at the c...
- Dr Reddy’s recalled all batches of heartburn drug from USRanitidine is commonly prescribed as an antacid and the NDMA impurity scandal had rocked Indian generic makers present in US who were one o...
- Batches of Strides' Ranitidine tablets now available for sale in AustraliaOut of the 135 batches of Ranitidine which were tested by TGA, 109 batches were found to have an NDMA level at or above the acceptable limi...
- Dr Reddy's recalls all its ranitidine products in USNDMA is classified as a probable human carcinogen based on results from laboratory tests. NDMA is a known environmental contaminant and fou...
- Ranitidine under lens after carcinogen alertIn India, a host of companies including GalxoSmithKline & Sun Pharma sell over 180 versions of the drug.
- Drug regulator steps up monitoring of ranitidineThe US FDA announced an update of testing of NDMA in ranitidine, warning manufacturers not to use a high-temperature test for NDMA as it ge...
- Strides Pharma shares plunge 8% as company suspends sales of ranitidine tablets in USOn the National Stock Exchange, it cracked 7.94 per cent to close at Rs 302.60.
- Strides Pharma suspends sale of Ranitidine tab in USIn a regulatory filing, the company said it has received an Information Request from the USFDA to provide test data related to NDMA impurit...
- GSK to recall Ranitidine from India after regulator alertBritish drugmaker will suspend release, distribution and supply of the heartburn drug.
Load More
